TY - JOUR
T1 - Nasal mucosal metastasis in a case of carcinoma esophagus
T2 - Case report and review of literature
AU - Yathiraj, Prahlad H.
AU - Patil, Asawari
AU - Ghosh-Laskar, Sarbani
PY - 2015/1/1
Y1 - 2015/1/1
N2 - A 60-year-old male, chronic alcoholic and smoker with decompensated cirrhosis was diagnosed with adenocarcinoma lower-third esophagus with multiple liver metastasis. While on palliative chemotherapy, the patient presented with a lesion at the tip of the nose. Excision of the lesion was performed suspecting mucormycosis. Histopathological examination revealed a poorly differentiated adenocarcinoma esophagus, similar to the initial disease. The nasal lesion recurred in 2 months, which was palliated with external radiotherapy given to the nasal lesion as well as the primary. The aim of this article is to present this rare case and review literature related to metastatic carcinoma of the esophagus with focus on nasal metastasis.
AB - A 60-year-old male, chronic alcoholic and smoker with decompensated cirrhosis was diagnosed with adenocarcinoma lower-third esophagus with multiple liver metastasis. While on palliative chemotherapy, the patient presented with a lesion at the tip of the nose. Excision of the lesion was performed suspecting mucormycosis. Histopathological examination revealed a poorly differentiated adenocarcinoma esophagus, similar to the initial disease. The nasal lesion recurred in 2 months, which was palliated with external radiotherapy given to the nasal lesion as well as the primary. The aim of this article is to present this rare case and review literature related to metastatic carcinoma of the esophagus with focus on nasal metastasis.
UR - http://www.scopus.com/inward/record.url?scp=84945130656&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84945130656&partnerID=8YFLogxK
U2 - 10.4103/0973-1482.139393
DO - 10.4103/0973-1482.139393
M3 - Article
C2 - 26458648
AN - SCOPUS:84945130656
SN - 0973-1482
VL - 11
JO - Journal of Cancer Research and Therapeutics
JF - Journal of Cancer Research and Therapeutics
IS - 3
ER -